In this paper, we reviewed the mechanisms and potential drugs of insulin signaling pathway in the treatment of T2DM complicated with HF to provide a comprehensive and detailed reference for relevant studies, and to contribute to the further research and development of new drugs for T2DM patients with HF. The gene discussed is INS; the disease is type 2 diabetes mellitus.